26. J.T. French, B. Goins, M. Saenz, S. Li, X. Garcia-Rojas, W.T. Phillips et al., Interventional
therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide.
J. Vasc. Interv. Radiol. 21, 1271–1279 (2010)
27. W.T. Phillips, B. Goins, A. Bao, D. Vargas, J.E. Guttierez, A. Trevino et al., Rhenium-186
liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma.
Neuro. Oncol. 14, 416–425 (2012)
28. S. Yook, Z. Cai, Y. Lu, M.A. Winnik, J.P. Pignol, R.M. Reilly, Radiation nanomedicine for
EGFR-positive breast cancer: panitumumab-modified gold nanoparticles complexed to the
b-particle-emitter,
177
Lu. Mol. Pharm. 12(11), 3963–3972 (2015)
29. S. Yook, Z. Cai, Y. Lu, M.A. Winnik, J.P. Pignol, R.M. Reilly, Intratumorally injected
177
Lu-labeled gold nanoparticles: Gold nanoseed brachytherapy with application for
neoadjuvant treatment of locally advanced breast cancer. J. Nucl. Med. 57(6), 936–942 (2016)
30. M.K. Khan, L.D. Minc, S.S. Nigavekar, M.S. Kariapper, B.M. Nair, M. Schipper et al.,
Fabrication of 198Au0 radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine 4(1), 57–69 (2008)
31. N. Chanda, P. Kan, L.D. Watkinson, R. Shukla, A. Zambre, T.L. Carmack et al., Radioactive
gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA198
AuNP nanoconstruct in prostate tumor-bearing mice. Nanomedicine 6(2), 201–209 (2010)
32. R. Shukla, N. Chanda, A. Zambre, A. Upendran, K. Katti, R.R. Kulkarni et al., Laminin
receptor specific therapeutic gold nanoparticles (
198
AuNP-EGCg) show efficacy in treating
prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 109(31), 12426–12431 (2012)
33. D. Cordier, F. Forrer, F. Bruchertseifer, A. Morgenstern, C. Apostolidis, S. Good et al.,
Targeted alpha-radionuclide therapy of functionally critically located gliomas with
213Bi-DOTA-[Thi8, Met(O2)11]-substance P: a pilot trial. Eur. J. Nucl. Med. Mol.
Imaging 37(7), 1335–1344 (2010)
34. R.M. de Kruijff, H.T. Wolterbeek, A.G. Denkova, A critical review of alpha radionuclide
therapy-how to deal with recoiling daughters? Pharmaceuticals Basel. 8(2), 321–336 (2015)
35. M.R. McDevitt, D. Ma, J. Simon, R.K. Frank, D.A. Scheinberg, Design and synthesis of
225
Ac radioimmunopharmaceuticals. Appl. Radiat. Isot. 57, 841–847 (2002)
36. L.L. Chappell, K.A. Deal, E. Dadachova, M.W. Brechbiel, Synthesis, conjugation, and
radiolabeling of a novel bifunctional chelating agent for
225
Ac. Radioimmunotherapy
applications. Bioconjug. Chem. 11, 510–519 (2000)
37. M.F. McLaughlin, J. Woodward, R.A. Boll, J.S. Wall, A.J. Rondinone, S.J. Kennel et al.,
Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy.
PLoS One 8(1), e54531 (2013)
442
S. W. Oh and D. S. Lee
therapy of head and neck cancer with lipid nanoparticle-carried rhenium 186 radionuclide.
J. Vasc. Interv. Radiol. 21, 1271–1279 (2010)
27. W.T. Phillips, B. Goins, A. Bao, D. Vargas, J.E. Guttierez, A. Trevino et al., Rhenium-186
liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma.
Neuro. Oncol. 14, 416–425 (2012)
28. S. Yook, Z. Cai, Y. Lu, M.A. Winnik, J.P. Pignol, R.M. Reilly, Radiation nanomedicine for
EGFR-positive breast cancer: panitumumab-modified gold nanoparticles complexed to the
b-particle-emitter,
177
Lu. Mol. Pharm. 12(11), 3963–3972 (2015)
29. S. Yook, Z. Cai, Y. Lu, M.A. Winnik, J.P. Pignol, R.M. Reilly, Intratumorally injected
177
Lu-labeled gold nanoparticles: Gold nanoseed brachytherapy with application for
neoadjuvant treatment of locally advanced breast cancer. J. Nucl. Med. 57(6), 936–942 (2016)
30. M.K. Khan, L.D. Minc, S.S. Nigavekar, M.S. Kariapper, B.M. Nair, M. Schipper et al.,
Fabrication of 198Au0 radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine 4(1), 57–69 (2008)
31. N. Chanda, P. Kan, L.D. Watkinson, R. Shukla, A. Zambre, T.L. Carmack et al., Radioactive
gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA198
AuNP nanoconstruct in prostate tumor-bearing mice. Nanomedicine 6(2), 201–209 (2010)
32. R. Shukla, N. Chanda, A. Zambre, A. Upendran, K. Katti, R.R. Kulkarni et al., Laminin
receptor specific therapeutic gold nanoparticles (
198
AuNP-EGCg) show efficacy in treating
prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 109(31), 12426–12431 (2012)
33. D. Cordier, F. Forrer, F. Bruchertseifer, A. Morgenstern, C. Apostolidis, S. Good et al.,
Targeted alpha-radionuclide therapy of functionally critically located gliomas with
213Bi-DOTA-[Thi8, Met(O2)11]-substance P: a pilot trial. Eur. J. Nucl. Med. Mol.
Imaging 37(7), 1335–1344 (2010)
34. R.M. de Kruijff, H.T. Wolterbeek, A.G. Denkova, A critical review of alpha radionuclide
therapy-how to deal with recoiling daughters? Pharmaceuticals Basel. 8(2), 321–336 (2015)
35. M.R. McDevitt, D. Ma, J. Simon, R.K. Frank, D.A. Scheinberg, Design and synthesis of
225
Ac radioimmunopharmaceuticals. Appl. Radiat. Isot. 57, 841–847 (2002)
36. L.L. Chappell, K.A. Deal, E. Dadachova, M.W. Brechbiel, Synthesis, conjugation, and
radiolabeling of a novel bifunctional chelating agent for
225
Ac. Radioimmunotherapy
applications. Bioconjug. Chem. 11, 510–519 (2000)
37. M.F. McLaughlin, J. Woodward, R.A. Boll, J.S. Wall, A.J. Rondinone, S.J. Kennel et al.,
Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy.
PLoS One 8(1), e54531 (2013)
442
S. W. Oh and D. S. Lee